Short-course neoadjuvant FOLFIRINOX versus upfront surgery for resectable pancreatic head cancer: A multicenter randomized phase-II trial (NORPACT-1) - Bratlie, SO; Biörserud, C; Björnsson, B (Journal of Clinical Oncology, 2023)
et al.